Preliminary Final Report
| Stock | Oneview Healthcare Plc (ONE.ASX) |
|---|---|
| Release Time | 26 Feb 2025, 8:06 a.m. |
| Price Sensitive | Yes |
Oneview Healthcare Plc Preliminary Final Report
- Recurring revenue up 9% to €7.18 million
- Total revenue up 5% to €9.89 million
- Loss after tax up 21% to €10.84 million
Oneview Healthcare Plc, a provider of software and related hardware for the healthcare sector, has released its preliminary final report for the year ended 31 December 2024. The company's revenue from continuing operations amounted to €9,894,534, an increase of 5% from the previous year. Recurring revenue, which includes software usage, content, support income, and license fees, grew by 9% to €7,176,170. As at 31 December 2024, the Oneview solution was live in 12,514 beds with a further 6,915 beds contracted but not yet installed. The company reported a loss after tax of €10,836,287, an increase of 21% compared to the previous year. This was attributed to higher sales and marketing expenses, product development and delivery expenses, and general and administrative expenses. The company did not declare or propose to pay any dividends for the year ended 31 December 2024. Oneview Healthcare Plc's financial statements are measured and recognised in accordance with International Financial Reporting Standards, as adopted by the European Union.